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1. INTRODUCTION AND BACKGROUND TO STUDY 
In current practice, the diagnosis of male infertility is largely dependent on semen analysis 
parameters. The World Health Organisation (WHO) recommends laboratory standards for 
the diagnosis of subfertility or infertility. These guidelines are periodically reviewed and 
updated. Semen parameters, such as motility, morphology, count and concentration, can 
be used to assess the quality of semen and to predict fertility potential (Cooper et al., 
2010). 
 
Although female factors account for the majority of cases of infertility, global data 
estimates that in up to 35% of infertile couples, a male factor can be demonstrated 
(Jungwirth et al., 2013). Local data suggests male factor infertility accounts for 21% of all 
cases (Chigumadzi et al., 1998). A normal semen analysis does not guarantee fertility, yet it 
remains the most accessible clinical format for assessing male factor subfertility and is 
considered the gold standard for this diagnosis (Sermondade et al., 2013). 
 
There are many known causes of male factor infertility. Among these, lifestyle factors such 
as obesity have been the focus of much research. If obesity is identified as causal to 
infertility, it represents a potentially modifiable risk factor. This has important implications 
especially, but not only, for lower socio-economic communities with restricted access to 
infertility treatments. The European Society for Human Reproduction and Embryology task 
force on ethics and law recommends weight loss as part of fertility treatment in women, 
but as yet has not made any recommendations for men (Dondorp et al., 2010). Extensive 
conflicting international data exist, but there is little published data focusing on the South 
African context. 
 
The WHO classifies body weight according to the body mass index (BMI). BMI is calculated 
by a person’s weight in kilograms divided by their height in meters squared. A BMI of less 
than 18.5 kg/m2 is defined as underweight, 25 to 29.9 kg/m2 as overweight, and over 30 
kg/m2 as obese (World Health Organisation, 1997). A healthy BMI range is between 18.5 
and 24.9 kg/m2. 
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When men in Khayelitsha, South Africa, were surveyed, 30% were found to be overweight 
or obese (Case et al., 2009). Similarly, the 1998 South African Demographic Health Survey 
found that 21% of South African men were overweight and a further 7% were obese 
(Puoane et al., 2002). Of concern is more recent data, in which South African men were 
found to have a 39% prevalence of being overweight and 14% prevalence of obesity (Ng et 
al., 2014). 
 
This study aims to address the lack of data on the link between BMI and infertility in the 
South African population by describing the prevalence of male overweight and obesity in a 
group of men undergoing infertility investigation, as well as assessing any semen analysis 
abnormalities in these groups. It also aims to describe how well men can predict their BMI 
category and determine whether weight loss would be an acceptable part of infertility 
management in overweight or obese male partners. Beliefs surrounding healthy weight and 
fertility will also be addressed. 
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2.   LITERATURE REVIEW 
2.1  PREVALENCE OF OBESITY AND SELF-PERCEPTION OF WEIGHT 
The Institution for Health Metrics and Evaluation at the University of Washington recently 
published a study evaluating the global change in prevalence of overweight and obesity 
from 1980 to 2013 (Ng et al,. 2014). A systematic analysis of data trends from 1 769 studies 
in 188 countries showed a global increase in the prevalence of overweight males from 
28.8% to 36.9%. In this study, South African men were found to have a 39% prevalence of 
being overweight, and 14% prevalence of obesity.  
 
This is an increase from the 1998 South African Demographic and Health Survey, which 
found 28% of men could be classified as obese or overweight (Puoane et al., 2002). When 
divided into racial groups, white males had a higher prevalence of being overweight or 
obese (54.4%) in comparison to black males (25%). A rural environment and younger age 
were seen to be protective.  
 
A survey from 2004-2005 of 500 randomly selected households in Khayelitsha, including 
975 adults, assessed BMI differences between age groups and genders (Case et al., 2009). 
Of the 417 men surveyed, 30% were found to be overweight or obese. Participants were 
asked about perception of both their current and ideal body image. Interestingly, men were 
found to underestimate their body weight and expressed a wish to gain further weight.  
 
Conflicting results were found in Kenya in a study conducted on 4 934 adults (Ettarh et al., 
2013). A lower rate of overweight or obesity was found (17.3%). A large proportion of men 
with a normal BMI felt that they were overweight (15%) or obese (13%). Twenty percent of 
men indicated an obese image as their ideal body size. The authors did not find cause for 
this. They hypothesised that this may be due to a cultural belief that associates obesity with 
health and wealth. 
 
An American study of African-American college students assessed body image perception in 
male graduates (Gross et al., 2005). Of the obese male group, only 39% perceived 
themselves as obese, while 63% of all males expressed body dissatisfaction. The application 
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of this sample to our study population is limited by the younger age and American context, 
but does suggest many men may underestimate their body weight category. 
 
The above literature illustrates that while obesity rates are increasing both locally and 
globally, very little is known about how South African males perceive their body image. 
There is no description, to the author’s knowledge, of the prevalence of obesity in men 
presenting to infertility units in South Africa.  
 
2.2  SEMEN ANALYSIS AND OBESITY 
Extensive research has been done to evaluate the possible impact of body weight on male 
fertility. This varies from large epidemiological studies extracting data from existing 
databases, to observational studies assessing patients presenting to infertility clinics. More 
recently, large meta-analyses have been conducted. Despite the large pool of data, no 
consensus has been reached. 
 
2.2.1  EPIDEMIOLOGICAL STUDIES 
Several epidemiological studies have fuelled the argument for a link between the 
prevalence of both overweight and obesity in men and infertility. Sallmén et al. (2006) used 
the data collected in the Agricultural Health Study (United States of America) to show that 
male obesity is associated with infertility. The study population consisted of 52 395 certified 
pesticide applicators and their spouses. Infertility was defined as more than 12 months of 
attempted conception within the four year study period, regardless of final conception 
outcome. The authors demonstrated an adjusted odds ratio of 1.12 (CI 95%, 1.01-1.25) of 
infertility in overweight men. They found a dose dependant relationship, with maximal 
effect at a BMI of 32-43kg/m2. This study provided the initial compelling evidence, but it has 
subsequently been heavily criticised. The infertility rate in this population was 28%, and 
despite being attributed by the authors to an increased sample mean age over 30, the use 
of pesticides in this group cannot be overlooked. Female causes of infertility were not 
excluded. BMI was self-reported, and may not have been the same at the time of infertility 
as at the time of data collection.  
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Ramlau-Hansen et al. (2007) extracted data from the Danish National Birth Cohort, 
consisting of 47 835 women and their partners. They demonstrated that overweight male 
partners (BMI 25-29.9 kg/m2) had an infertility odds ratio of 1.15 (95% CI 1.09-1.22), and 
obese partners (>30 kg/m2) had an odds ratio of 1.49 (95% CI 1.34-1.64). The authors 
defined infertility as any period of twelve months with unsuccessful attempted conception 
within the study period. The birth registry only documents live births. This therefore 
excluded all couples who failed to conceive at all during the study period, as well as those 
who did conceive but miscarried. BMI was reported two years after the attempted 
pregnancy. Women with known causes of infertility were excluded, but this would have 
been dependent on the woman involved seeking medical treatment and obtaining a 
diagnosis. 
 
Nguyen et al. (2007) conducted the Norwegian Mother and Child cohort study, a secondary 
analysis of a Norwegian database. Using data from 26 303 women and their partners, they 
found that overweight men had an infertility odds ratio of 1.19 (95% CI 1.03-1.62), and 
obese men an odds ratio of 1.36 (95% CI 1.12-1.62). A dose-response relationship was also 
demonstrated, with a plateau over a BMI of 35 kg /m2. Women reported their partners’ 
BMI, and infertility was defined as greater than 12 months to time of pregnancy (resulting 
in live birth). This study was criticized for the use of self-reported BMI and definition of 
infertility in terms of live birth outcomes. The partner’s BMI was documented at the time of 
pregnancy, but not during the time of subfecundity. The authors conducted a small validity 
study which showed good correlation between the partners’ reported BMI and actual BMI. 
Factors known to affect female fertility were not corrected for. The documentation of coital 
frequency did show that the association between male infertility and obesity is not solely 
explained by sexual dysfunction.  
 
The findings of these studies have been summarized in Appendix A on page 47. 
 
2.2.2  INFERTILITY CLINIC COHORT STUDIES 
Several studies of couples presenting to infertility clinics have shown a link between male 
obesity and infertility. Magnusdottir et al., (2005) documented a three times higher 
incidence of male obesity in patients with male factor subfertility. Seventy-two male 
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partners presenting to infertility clinics were divided into three groups: male factor 
subfertility, idiopathic subfertility, and female factor subfertility. The authors’ primary 
objectives were to compare levels of polychlorinated biphenyls and organochlorine 
pesticides in plasma and semen to assess environmental impact on fertility. 
 
Another study classified men presenting to an infertility clinic into non-obstructive 
azoospermia, oligoasthenospermia, and normozoospermia (Zorn et al., 2006). The BMI of 
the men in these groups was then correlated, and found to be, on average, 27, 26, and 25 
kg/m2 respectively. They demonstrated an insignificant increase in BMI among men with 
non-obstructive azoospermia relative to normozoospermic men. These values were all 
within the same overweight BMI category, and are therefore of little clinical significance. 
 
The findings of these studies have been tabulated in Appendix B, on page 48. 
 
2.2.3  STUDIES REVIEWING SEMEN ANALYSIS PARAMETERS 
Before discussing the literature, it is important to distinguish between sperm concentration 
and total sperm count as reported in many studies. Concentration is a measure of 
spermatozoa, in millions per millilitre. Total count is a measure of spermatozoa in millions 
per ejaculate. The WHO has changed their lower reference limits five times since 1980. We 
currently use the guidelines set in 2010 (Appendix C, page 49). Many studies have used 
former guidelines, as were applicable at the time. These discrepancies will be highlighted 
where relevant. A table with all the results of cited studies’ have been included for ease of 
reference. This can be found in Appendix D on page 50. 
 
Research examining the relationship between obesity and semen quality has provided 
conflicting results. In one of the most frequently cited studies, Jensen et al. (2004) assessed 
1 558 Danish military recruits. BMI was directly measured. The participants were subjected 
to a questionnaire and a physical examination. After correcting for diseases of reproductive 
organs, they found that men with a BMI >25 kg/m2 had a 21.6% decrease in their sperm 
concentration, when compared to normal-weighted counterparts (no odds ratios 
published). Total sperm count was also reduced by 23.9%. The actual values were however 
not below the WHO lower reference limits.  
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No link between BMI and sperm motility, volume, or morphology was found. An analysis of 
sperm morphology is difficult due to the high inter-individual variability observed and a lack 
of standardisation. Jensen et al. (2004) applied strict WHO criteria and used only one 
investigator to analyse the morphology in all of their samples. No relationship was found 
between morphology and an increasing BMI. This was despite higher reference values 
having being used, as per previous WHO guidelines.  
 
Another well cited study assessed anthropometric measures of male partners instead of 
BMI (Fejes et al., 2005). The study included 81 couples presenting to an infertility centre. 
The men were subjected to a detailed questionnaire, a medical examination and endocrine 
testing. This was done in order to exclude men with an undiagnosed cause of secondary 
infertility. Two semen samples, taken three weeks apart, were collected and the best result 
was used. This has been criticized as masking the significant sperm quality differences 
between weight groups (Hammoud et al., 2008). The sperm concentration was negatively 
correlated (weakly) with hip circumference. Total sperm count also correlated negatively to 
hip circumference, weight, and waist circumference. Since weight is only relevant when 
defined in terms of BMI, these findings are of questionable clinical significance. Total sperm 
count did not correlate with waist-hip ratio. There was no difference between the 
oligozoospermic and normozoospermic groups, or the asthenzoospermic and normal 
motility groups in terms of anthropometric data. This study used older WHO guidelines, 
with higher cut off values. 
 
Kort et al. (2006) assessed male partners presenting to an infertility centre and found that 
an increase in BMI inversely correlated with sperm motility. Men with previous surgery 
were excluded. BMI was recorded on the day of sample production. The author used 
normal motile sperm (NMS) as a measure of motility. This is calculated by multiplication of 
volume, concentration, motility and morphology. The NMS for obese men was much lower 
than that of the healthy BMI category (0.7 versus 18.6 respectively). There was no 
statement of normal values for NMS. It must be kept in mind that as there are four 
variables in the NMS calculation, a large change in one may affect the result.  
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Hammoud et al. (2008) conducted a retrospective analysis of 390 male partners presenting 
to an infertility clinic for semen analysis. Obesity was associated with an odds ratio of 3.3 
(95% CI 1.19-9.14) for oligozoospermia, using a cut off of 20 million sperm per ejaculate. 
The range in confidence interval should be noted. In current practice, this concentration 
value would be viewed as normal. Overweight and obese men formed 43% and 32% of their 
population sample respectively, which was higher than national norms. Unfortunately, this 
paper published limited results, and used bar graphs with no data sets. The authors also 
demonstrated the existence of relationships between obesity and both reduced motile 
sperm count and increased abnormal sperm morphology. Obese men had higher abnormal 
morphologies [odds ratio of 1.6 (95% CI 1.05-2.59)]. They did not state what their cut off 
value was, but it can be assumed to be 15%, in keeping with the guidelines of the time. Due 
to the absence of tabulated data in their publication, the actual values obtained cannot be 
commented on. 
 
Aggerholm et al. (2008) collected data from five population based environmental studies of 
semen quality. Height and weight were self-reported, and BMI was classified into 
categories. They chose to define underweight as a BMI < 20 kg/m2. Later they re-analysed 
the data using standard WHO BMI groupings, and found no difference in results. A total of 
1 989 men were included in the study. The authors found that normal-weighted men had a 
higher sperm concentration (59 vs 56 x 106/ml) and total sperm count (168 vs 154 million) 
in comparison to overweight men, but lower than those of obese men (68 x 106/ml, and 
190 million sperm respectively). None of these results were statistically or clinically 
significant. 
 
Men presenting to an academic fertility clinic in America were recruited for a six year 
period to assess the impact of various lifestyle factors on infertility (Chavarro et al., 2010). 
This study included 483 men, after exclusion of four underweight and 17 azoospermic men 
(to prevent the data being skewed).  Seventy-five percent of men were overweight or 
obese. After adjustment for confounding factors, increasing BMI was associated with a 
decrease in semen volume (2.9 ml vs 3.0 ml). These values still fall within current normal 
reference ranges. Overweight men were found to have a higher total progressive sperm 
count than their normal-weighted counterparts.  This finding could not be explained. After 
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further dichotomized analyses for semen analysis parameters were conducted, it was 
suggested that overweight and obesity were associated with a non-significant increased 
rate of below reference sperm concentration and morphology.  
 
These findings are contradicted by the findings of Relwani et al. (2011). The authors 
included 530 men, and found no consistent relationship between sperm concentration, 
motility, or morphology and increasing BMI. BMI was self-reported. Similar results were 
obtained in a retrospective study conducted in Saudi Arabia on a cohort of 500 men 
(Eskandar et al., 2011). The groups were divided into obese and non-obese males. No 
difference in semen analysis parameters was found. None of the findings were statistically 
significant.  
 
Shayeb et al. (2011) analysed 2 035 sperm samples in a Scottish infertility database. Forty-
one percent of the men in this group were overweight and 13% were obese, which is 
representative of the Scottish population. There was no association between BMI and 
sperm concentration, total sperm count, progressive motility, semen volume, or the total 
number of morphologically normal, and progressively motile spermatozoa per ejaculate. 
Sperm with normal morphology were found to be more prevalent in the normal and 
underweight men than in the overweight and obese men. This was based on previous WHO 
lower reference limits, using a cut off value of 15%. The mean morphology in the obese 
group was 6% - a value considered normal by current guidelines. After adjustments for 
lifestyle factors, obese men were more likely to have a low ejaculate volume (<2 ml) 
compared with men with a normal weight (adjusted odds ratio of 1.69; 95% CI 1.20-2.38). 
Again, this cut off value of 2 ml is based on previous guidelines. Current guidelines 
reference 1.5 ml and above as normal.  
 
Recent publications include a 16 year retrospective study of 2 110 men (Al-Ali et al., 2014). 
Data captured before 1999 was analysed according to WHO standards published in 1992, 
and data after 1999 according to 1999 guidelines. The publication does not print standard 
results, but rather classified abnormal mean morphology as a percentage, quoting non-
significant results of between 62 and 63% across all BMI categories. Both mean sperm 
concentration and motility did not vary across the normal and overweight or obese groups. 
The authors concluded there was no impact of BMI on semen analysis parameters.  
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Belloc et al. (2014) contradicted this by publishing their findings of BMI affecting all 
parameters except morphology. Self-reported weight and height were routinely recorded in 
their laboratory and a retrospective analysis of 10 665 men was carried out. Semen volume 
means decreased from 3.3 ml to 2.7 ml as BMI increased, but these values were still within 
current normal ranges. The same can be said of their findings for sperm concentration 
means (56.4 x 106/ml to 39.4 x 106/ml) and total sperm count (171 million to 92 million). 
Again these results remain above normal limits. They also found a progressive motility 
decrease from 36.9% to 34.7%. When adjusted for confounding factors such as age and 
abstinence, these findings were consistent. Again, it is important to note that findings were 
not below clinical reference values.  
 
2.2.4 HYALURONAN BINDING & SPERM FUNCTION TESTING 
Intracytoplasmic sperm injection (ICSI) has become the technique of choice for male factor 
infertility or failed fertilization in standard IVF cycles. When IVF was in its infancy, it was 
found that the spermatozoa of infertile men frequently demonstrated abnormal acrosome 
reaction, or sperm-zona pellucida interaction (Oehninger et al, 2014). Subsequently, zona 
pellucida assays and acrosome reaction tests were developed as further investigation for 
the infertile couple. 
 
The WHO currently regards sperm functional tests as of research value, due to their 
complexity and difficulty in implementation in routine practise. (Oehninger et al, 2014). 
Such testing includes sperm penetration assays, sperm-zona pellucida binding tests, 
acrosome reactions, and hyaluronan binding. It can be hypothesized that an increased BMI 
may affect the fertilization potential of the spermatozoa. Most research around such 
testing has focused on their validation for directing couples to ICSI rather than intrauterine 
insemination or IVF. After an extensive literature search, no relevant human studies were 
found that detail the effect of obesity on sperm function testing, other than for hyaluronan 
binding.  
 
Hyaluronan binding (HA-binding) of sperm is a relatively new sperm function test that has 
shown an improved quantification of sperm quality (Huszar et al., 2006). It is thought to be 
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a marker of complete spermatogenesis and is used to identify mature sperm with normal 
chromosome development and oocyte-binding function.  
 
Wegner et al. (2010) assessed 107 male patients presenting to a fertility laboratory and 
grouped them into standard BMI categories. Height and weight were self-reported. An HA-
binding score of 80% was associated with improved sperm quality, measured by higher 
mean sperm concentrations, normal morphology scores, and higher percentage motile 
sperm scores. They correlated an increase in BMI with a decreasing HA-binding score, 
following a dose-response relationship. The authors failed to correlate any other sperm 
parameters with an increase in BMI. 
 
2.2.5  META-ANALYSES 
MacDonald et al. (2010) conducted a meta-analysis of all of the existing research on BMI, 
sperm parameters and hormone profiles. They excluded all animal studies and any studies 
with small sample sizes (less than 100 participants). They also excluded studies where 
samples had extremes of age, organic reproductive disorders, azoospermia, exposure to 
toxins, and those based solely on fertile couples who achieved pregnancy. In total, 6 793 
men from 13 studies were included. No relationship between BMI and semen parameters 
was found. They commented that their stringent exclusion criteria may have excluded data 
that may have resulted in a relationship.  
 
A second meta-analysis was conducted in 2012, including 21 studies conducted until June 
2012 (Sermondade et al., 2012). A total of 13 077 men were included from both the general 
population and those attending infertility clinics. A dichotomized analysis was required to 
find significant results. A J-shaped graphical curve was found between BMI and both 
abnormal total sperm count, and abnormal sperm concentration. In the very obese group 
(>35), the odds ratio of abnormal total sperm count and concentration was 2.04 (95% CI 
(1.59-2.62), and 1.97 (95% CI 1.27-3.07) respectively.  The authors felt that due to the large 
sample size and inclusion of studies performed after the 2010 meta-analysis, their work 
represented the true relationship between an increased BMI and parameters of semen 
analysis 
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2.3. SOUTH AFRICAN RESEARCH   
In contrast to numerous international studies, local data are lacking. A recently published 
pilot study conducted by the University of the Western Cape recruited men between the 
ages of 21 and 50 attending private clinics in the Western Cape (Leisegang et al., 2014). The 
primary focus of this study was to correlate seminal insulin and leptin levels with semen 
analysis parameters. The authors hypothesized that as abdominal obesity is associated with 
raised plasma insulin and leptin levels, an alteration in seminal levels could translate to 
impaired reproductive potential. Men with known infertility, vasectomy, genital tract 
pathology, and known chronic diseases were excluded. After obtaining a detailed history 
and conducting a physical examination, patients with a new diagnosis of chronic disease or 
genital tract pathology were further excluded. A cohort of 42 patients was recruited, 
consisting of 23 obese, and 19 normal or overweight men.  
 
Lower mean values were demonstrated in the obese group for total sperm count, 
progressive and total motility. These results were not statistically significant. Significance 
was only proven in the lower mean values for vitality and sperm concentration. Despite 
these results, only a decrease in vitality and progressive motility were below the 
recommended 2010 WHO reference values. For ease of reference, the relevant results have 
been attached as appendix E on page 57. 
 
Weaknesses of this study include the small sample size, predominantly Caucasian 
demographic (not representative of the local population), and the grouping of overweight 
and normal BMI patients into the same group. This seems to be the only South African 
study investigating the impact of weight on semen analysis parameters. The previously 
mentioned study published on the infertility profile at King Edward VIII Hospital in Durban 
(Chigumadzi et al., 1998) assessed women, and only documented the prevalence of male 
factor infertility. 
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3. AIMS AND OBJECTIVES 
3.1 AIMS 
This study aimed to document the prevalence of overweight and obesity in male partners 
of infertile couples undergoing investigation at a tertiary referral institution, and to assess 
the impact of raised BMI on semen quality. 
 
3.2 OBJECTIVES 
3.2.1 PRIMARY OBJECTIVES 
1. To document the BMI of the male partners of infertile couples presenting for 
semen analysis. 
2. To record the results of the semen analysis of the same subjects. 
3. To assess whether an association exists between the male BMI and clinically 
significant parameters of semen analysis suggestive of infertility. 
 
3.2.2 SECONDARY OBJECTIVES 
1. To record the subjects’ self-perceived BMI category. 
2. To assess subjects’ beliefs on the impact of overweight and obesity on fertility. 
3. To record the subjects’ willingness to lose weight as a fertility improvement 
strategy. 
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4 METHODS  
4.1 STUDY DESIGN 
This was a prospective cross-sectional study. 
 
4.2  STUDY POPULATION AND STUDY SETTING 
Men presenting to the Groote Schuur Reproductive Medicine Unit for semen analysis as 
part of infertility investigations were consecutively recruited into the study. Referrals to this 
unit were made from gynaecology outpatients departments within the service district. 
Patients were seen on a Monday and Wednesday at the Andrology Laboratory in Groote 
Schuur Hospital. They provided a semen sample, which was analysed by clinical 
technologists within one hour of production as per routine practice. 
 
4.3 STUDY DURATION 
Patients were recruited for a period of five months, from 01 June 2014 to 12 November 
2014. 
 
4.4 SAMPLE SIZE 
The sample size was determined by the time frame of this thesis, which allowed five 
months for data collection. No power calculation was done. It was anticipated that the 
results of this study would provide relevant information upon which a larger, appropriately 
powered study could be based in future. 
 
4.5 INCLUSION CRITERIA 
1. All men presenting to the Reproductive Medicine Unit at Groote Schuur Hospital 
who successfully produced a sample for semen analysis as part of an infertility 
investigation were eligible to participate. 
2. All men who were able to communicate in English, Afrikaans, or Xhosa were 
included. 
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4.6 EXCLUSION CRITERIA 
1. Patients who were unwilling to be recruited. 
2. Patients who had not abstained from sexual intercourse for three days prior to 
providing the sample. 
3. Post-vasectomy patients. 
 
4.7 STUDY RECRUITMENT 
Suitable study participants were approached in the waiting area of the Andrology 
Laboratory by the principal investigator or by staff working in the Reproductive Medicine 
Unit. Prospective participants were spoken to in a private setting and informed about the 
study objectives, detailing what their participation would entail. All participants provided 
written informed consent (Appendix F, page 58). 
 
4.8  DATA COLLECTION 
The subjects’ weight and height was collected using the same scale. A questionnaire was 
administered (Appendix G, page 59). The questionnaire addressed whether the men 
thought they were overweight or obese, and whether they thought their weight would 
affect the outcome of the semen analysis. They were asked if they would be willing to 
embark on a weight loss program if one was provided as a part of their management. This 
questionnaire was translated into Afrikaans and Xhosa.  
 
Semen samples were provided by masturbation. The samples were then analysed within 
the Reproductive Medicine Unit using standard 2010 WHO protocol. This analysis was done 
as a part of the routine infertility investigation. This study only captured the data 
generated. 
 
Three qualified and experienced embryologists working in the Reproductive Medicine Unit 
performed the semen analysis.  
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4.9 DATA PROCESSING AND STATISTICAL ANALYSIS 
The study participants were each allocated a study number. Their height and weight was 
captured on the questionnaire. All questionnaires were stored within the department. The 
semen analysis results were recorded in the laboratory register with the corresponding 
study number.  
 
The data were analysed using descriptive statistics. Numerical data were described using 
appropriate summary statistics, such as the mean, standard deviation, median and range, 
followed by testing of the data’s distribution to inform the choice of statistic. Results were 
graphically displayed using bar graphs, frequency histograms, and scatter plots. 
 
Four analyses of BMI and semen analysis parameters were conducted. BMI was compared 
to semen analysis parameters, both assessed as continuous variables. As all of the data was 
non-normal, the non-parametric Spearman’s correlation was used.  
 
Next, each semen analysis parameter was classified as either normal or abnormal on the 
basis of WHO 2010 guidelines, to assess clinical relevance of findings. These dichotomised 
parameters were compared to continuous BMI values. Mann-Whitney U tests were used to 
test whether there was a significant difference in the BMI values associated with the 
normal and abnormal results. Sperm forward progression was analysed using the Kruskal-
Wallis test. 
 
BMI was then categorised (namely < 25 kg/m2, >25 kg/m2, >30 kg/m2). This was compared 
to unclassified semen analysis parameters (continuous variables). Mann-Whitney U and 
Kruskal-Wallis tests were applied again.  
 
Lastly, categorised BMI values were compared to classified semen analysis values, and a 
series of 3x2 frequency tables were generated. Each of the frequency tables was then 
analysed using Pearson’s chi-square test and Fisher’s exact test. These tests were 
conducted to check whether the distribution of observations across the frequency table 
could occur by chance, if they were taken from the same base population. 
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4.10 ETHICS 
Ethics approval was obtained from the Human Research Ethics Committee of the Faculty of 
Health Sciences of the University of Cape Town (HREC/REF: 171/2014). 
 
Confidentiality was maintained by all involved in the study, as the semen analysis formed 
part of the subjects’ medical records. Eligible patients who declined to participate in the 
study were assured that it would not compromise their treatment. Any queries that the 
subjects had were answered by the investigators, and the relevance of the questionnaire 
was explained. The participants were assured that their involvement was strictly voluntary 
and that they could withdraw at any stage without an explanation. No monetary incentives 
were offered to participate in the study. 
 
All of the data were collated and processed by the principal investigator, under the 
supervision of the study supervisors.  
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5.  RESULTS 
5.1 DESCRIPTIVE AND QUALITATIVE DATA 
One hundred and thirteen men were recruited into the study between June 2014 and 
November 2014. Their average weight was 83.5 kg, with a range of 51.2kg-133.3kg. The 
average BMI was 27.1 kg/m2, with a range of 17.4 kg/m2-43.1 kg/m2 (Table 1). 
 
Table 1 – Descriptive statistics for the continuous variables weight, height and BMI. 
Variable N Minimum Maximum Mean Std. 
Dev. 
Median p25 p75 
Weight (kg) 113 51.2 133.3 83.5 16.3 81.7 71.9 92.4 
Height (m) 113 1.6 2.0 1.8 0.1 1.8 1.7 1.8 
BMI (kg/m2) 113 17.4 43.1 27.1 5.0 26.3 23.6 30.1 
 
BMI is usually categorised into four categories, underweight, normal, overweight and 
obese. As very few of the men in this sample were underweight, the categories of 
underweight and normal were combined.  
 
There was a good representation across the three BMI categories, with 36.28% of the men 
demonstrating a BMI <25kg/m2, 38.05% a BMI between 25kg/m2 and 30kg/m2, and 25.66% 
a BMI >30kg/m2. Figure 1 illustrates the distribution of BMI values. 
 
The first section of the questionnaire asked the men to categorise their own BMI. Sixty-six 
percent of them felt they were “normal”, 25% felt that they were slightly overweight, 5% 
felt that they were underweight and 2% thought that they were very overweight. 
 
Figure 2 illustrates how self-perceived weight correlated with actual BMI categories. The 
majority of the men who felt that they were underweight were actually of recommended 
BMI. Most of the men who felt that they were of a normal weight had a BMI of >25 kg/m2 
and most of the men who felt that they were slightly overweight were actually in the obese 
BMI category. Less than half of the men (40.7%) assessed their body weight correctly. In the 
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incorrect group, 28.2% were out by two BMI categories. The 2% of the men who felt that 
they were very overweight had a BMI closest to 25 kg/m2. 
 
The second section of the questionnaire assessed the men’s perceptions of body weight 
and reproductive potential. Fifty-one of the men (45.13%) felt that being overweight could 
negatively influence fertility. Twenty-four (21%) did not think being overweight influenced 
fertility and thirty-eight did not know (33%). 
 
The third aspect of the questionnaire assessed whether the men were willing to partake in 
a weight loss programme if it was offered to them as a part of their fertility treatment. 
Eighty-seven percent of the men indicated that they would. Of the eight men who said no, 
five had a BMI of 25 kg/m2 or less and three had a BMI greater than 30kg/m2.  
 
 
 
 
 
 
 
 
 
 
 20 
 
Figure 1 – Frequency of BMI. 
 
Figure 2 - Comparison of self-perceived BMI and actual BMI. 
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5.2 SEMEN ANALYSIS FINDINGS 
Semen analysis was conducted on the 113 men. Six variables were measured, four 
continuous variables (volume, pH, motility and concentration) and two ordinal variables 
(morphology and sperm forward progression (SFP)). The term sperm concentration is used 
instead of sperm count (106/ml) to avoid confusion with the similar-sounding term “total 
sperm count” (millions per ejaculate). Figure 3 shows the frequencies of the measurements 
collected for these variables. 
 
Table 2 provides further descriptive statistics of the continuous variables and of the ordinal 
variable morphology. As SFP has six categories, it is instead summarised by frequency 
tables, given in Table 3 (page 24). 
 
Each of the variables can be used to classify a man’s semen analysis results as normal or 
abnormal using WHO suggested reference ranges. This categorisation was done to ensure 
that the results found here were of clinical relevance. Appendix C (page 49) defines the 
2010 WHO reference ranges. 
 
Only 29% of the men were classified as having normal values for every variable in the 
semen analysis, as defined by the WHO guidelines.  
 
The men had a mean semen volume of 3.0 ml, with a range of 1.0-9.0 ml. Eighty-three 
percent of the men had a normal volume. The men had an average pH of 7.5, with a range 
of 6.7-8.0. Eighty-six percent of the men had a pH within the normal range.  
 
Motility was analysed in terms of percentage and SFP. One hundred and six men were 
included in the assessment, as the motility cannot be calculated when there are no sperm, 
i.e., in a sperm concentration of 0. The men with motile sperm had on average 41.9% 
motile sperm in their semen samples, with a range of 0-80%, and 62.83% of these men had 
a normal motility. 
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SFP was assessed on a scale of 0 to 4. A value of 2 was taken as normal for our study 
purposes, but none of the men had an SFP value of 2. Eighty-four percent of the men had 
an SFP of 2+ or greater.  
 
All 113 men were included in the sperm concentration analysis. The mean was 47.3 x 106 
per ml, with a range of 0-140 x 106 per ml. Seventy-nine percent of the men had a normal 
sperm concentration. Seven men had a concentration of 0, and a further fifteen had a 
concentration of 10 or less.  
 
Morphology was not analysed in samples with a concentration of less than or equal to 10 x 
106 per ml. Thus 22 samples were excluded from this analysis, leaving 91 men. The average 
morphology was 5%, with a range of 1-16.  Of the 91 men who were analysed, 71.43% had 
a normal morphology result, and of the total 113 men, 57.52% had a normal morphology 
result. 
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Figure 3 – Frequencies of the measurements taken for semen volume, semen pH, sperm 
motility, SFP, sperm concentration, sperm morphology. 
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Table 2 - Descriptive statistics for the continuous variables and morphology measured 
during the semen analysis. 
 
Table 3 – Frequency table for the collected SFP data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable N Minimum Maximum Mean Std. 
Dev. 
Median p25 p75 
Volume (ml) 113 1.0 9.0 3.0 1.6 2.5 2.0 4.0 
pH 113 6.7 8.0 7.5 0.3 7.5 7.2 7.5 
Motility (%) 106 0.0 80.0 41.9 18.9 50.0 33.8 55.0 
Concentration 
(x106/ml) 
113 0.0 140.0 47.3 40.2 35.0 18.0 80.0 
Morphology 
(%) 
91 1 16 5.29 2.59 5 3 7 
 SFP 
 Frequency Percent 
0 5 4.42 
1 5 4.42 
2+ 5 4.42 
3 41 39.82 
3+ 46 40.71 
Total (N) 106 100 
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5.3 COMPARISON OF SEMEN ANALYSIS AND BMI 
5.3.1 CONTINUOUS BMI VARIABLES VERSUS UNCLASSIFIED FERTILITY MEASURES 
The complete data sets of each of the continuous variables (without first categorising each 
measured variable as either normal or abnormal) were compared with one another. As all 
the data were non-normal, the non-parametric Spearman’s correlation was used. 
Spearman’s correlation coefficient is a statistical measure of the strength of a monotonic 
relationship between paired data. The closer the result is to 1, the stronger the monotonic 
relationship. P-values of less than 0.01 were defined as very significant, and less than 0.05 
were defined as significant. These results are displayed in Table 4 (page 27). 
 
A significant, strong, positive correlation was found between motility and SFP of 0.693 (p < 
0.001), as both are measures of how well sperm moves. This was statistically significant. 
 
Sperm concentration correlated moderately with SFP (0.586, p < 0.001), and strongly with 
motility (0.676, p < 0.001). This finding is intuitive, as an increase in concentration would 
result in a higher likelihood of an increased number of motile and forward-progressing 
sperm. These findings were strongly significant at the 0.01 level. 
 
Morphology was weakly correlated with sperm concentration (0.325, p = 0.002). The 
relationship between concentration and morphology can be explained using the same 
rational as the motility argument addressed above.  
 
The evaluation of BMI with semen variables demonstrated that BMI and motility were 
correlated weakly (0.263, p = 0.006) at the 1% level. There was also a very weak correlation 
between BMI and sperm concentration (0.186, p = 0.049), significant at the 5% level. Both 
BMI vs. concentration and BMI vs. motility did not show any clear relationship (Figure 4, 
page 26). For comparison, the strong, highly significant correlation between SFP and 
motility is also plotted, in which a clear monotonic increasing relationship can be seen. 
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Figure 4 – Comparison of motility and SFP; concentration and BMI; and motility and BMI, 
indicating a strong correlation well represented by a monotonic positive relationship and 
two weak correlations, respectively. 
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Table 4 - Correlations between the continuous BMI measurements and the continuous 
semen variables. 
 
 BMI Volume SFP Motility Concentration Morphology 
Spearman's 
rho 
BMI Correlation 
Coefficient 
1.000      
Sig.            
(2-tailed) 
.      
N 113      
Volume Correlation 
Coefficient 
.133 1.000     
Sig.            
(2-tailed) 
.161 .     
N 113 113     
SFP Correlation 
Coefficient 
.090 .048 1.000    
Sig.            
(2-tailed) 
.359 .627 .    
N 106 106 106    
Motility Correlation 
Coefficient 
.263** .096 .693** 1.000   
Sig.            
(2-tailed) 
.006 .328 .000 .   
N 106 106 106 106   
Concentration Correlation 
Coefficient 
.186* .063 .586** .676** 1.000  
Sig.            
(2-tailed) 
.049 .505 .000 .000 .  
N 113 113 106 106 113  
Morphology Correlation 
Coefficient 
.087 -.157 .073* .125* .325** 1.000 
Sig.            
(2-tailed) 
.410 .138 .492 .239 .002 . 
N 91 91 91 91 91 91 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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5.3.2 CONTINUOUS BMI VALUES VERSUS CLASSIFIED FERTILITY MEASURES  
Each of the measured variables of semen quality has a reference value for normality. Each 
individual was classified as either normal or abnormal for each parameter. Table 5 (page 
29) shows the descriptive statistics of the BMI values for each group of normal/abnormal 
individuals, as classified by each measurement. 
 
This categorisation to test the correlations found when applying non-parametric testing 
was done to determine any clinical significance. Mann-Whitney U tests were used to test 
whether there was a significant difference in the BMI values associated with the normal 
and abnormal individual parameters. As well as testing the two groups with normal and 
abnormal SFP values, a Kruskal-Wallis test was conducted on the BMI values associated 
with the five groups of raw SFP scores (0, 1, 2, 3, 4+). Table 6 (page 30) indicates the test 
statistics and the probability of homogeneity. 
 
P-values of greater than 0.05 were obtained from almost all of the tests, indicating that the 
null hypothesis of homogeneity was not rejected: there was no significant difference in the 
BMI values for the normal and abnormal individuals, as measured by most of the 
categorised semen analysis results. The exception was motility.  
 
The median values of BMI were significantly different between the <40% and >=40% 
categories of motility [median=24.98, IQR=(21.52-28.45) and median=27.55, IQR=(24.52-
30.99) respectively]. The p-value was 0.026. Both inter-quartile ranges were widely 
distributed. 
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Table 5 – Descriptive statistics of the BMI values in each group of normal/abnormal 
fertility patients, as classified by each measurement. 
 
  BMI 
N Min Max Mean Std. 
Dev. 
Median Percentile  
25 
Percentile  
75 
Question 1: How 
would you describe 
your weight? 
Underweight 6 17.45 25.28 21.71 3.15 21.71 19.17 24.98 
Normal 75 18.66 40.69 26.11 4.42 25.74 23.06 28.55 
Slightly 
Overweight 
29 24.42 43.15 31.14 4.34 30.96 27.77 33.93 
Very 
Overweight 
3 22.01 25.28 23.93 1.71 24.50 23.25 24.89 
SFP 0 5 18.81 30.52 26.06 4.49 26.98 25.28 28.69 
1 5 20.78 40.73 29.34 7.37 27.99 26.24 30.96 
2+ 5 17.45 40.69 26.63 8.82 26.09 21.32 27.58 
3 45 18.66 36.57 26.68 4.65 25.40 23.29 29.44 
3+ 46 19.17 43.15 27.70 4.99 27.67 23.88 31.15 
pH <7.2 15 22.56 35.53 27.24 4.16 26.30 24.21 29.80 
>=7.2 98 17.45 43.15 27.09 5.11 26.27 23.44 30.15 
Volume <=1.5 15 18.81 36.57 25.80 4.93 25.40 23.25 27.22 
>1.5 98 17.45 43.15 27.31 4.99 26.93 23.84 30.16 
Motility <40 35 17.45 40.73 25.95 5.92 24.98 21.52 28.45 
>=40 71 18.66 43.15 27.84 4.57 27.55 24.52 30.99 
Concentration <15 23 17.45 40.73 25.93 6.94 24.91 20.96 28.34 
>=15 90 18.66 43.15 27.45 4.72 26.96 23.84 30.63 
SFP <2 10 18.81 40.73 27.70 6.01 27.48 25.28 30.52 
>=2 96 17.45 43.15 27.17 5.04 26.44 23.36 30.40 
Morphology < 4 26 18.66 36.54 26.20 4.68 25.99 23.29 28.43 
 >= 4 65 19.19 43.15 27.82 4.77 27.58 24.42 30.92 
BMI <25 41 17.45 24.80 22.15 1.99 22.56 20.85 23.78 
25-30 43 24.98 29.94 27.30 1.38 27.50 26.10 28.24 
30+ 29 30.15 43.15 33.75 3.29 33.59 31.15 34.52 
 30 
 
Table 6 – Test statistics indicating the probability of homogeneity in BMI values between 
individuals with normal and abnormal fertility, as measured by each 
measurement. 
Mann-Whitney U tests of significance 
Variable Test 
statistic 
p-value 
SFP 2.118 0.714 
pH -0.157 0.876 
Volume 1.172 0.241 
Motility 2.22 0.026 
Concentration 1.836 0.066 
Morphology 1.524 0.127 
SFP (Re-categorised) -0.303 0.762 
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5.3.3 CLASSIFIED BMI VALUES VERSUS UNCLASSIFIED FERTILITY MEASURES  
In the previous section, each semen analysis parameter was used to classify each individual 
as normal or abnormal, and then Mann-Whitney U tests were used to check whether 
normal and abnormal individuals differed in their BMI. We then classified each individual on 
the basis of their BMI as either underweight, normal, overweight, or obese. As there was 
only one underweight individual, the underweight and normal categories were combined. 
Kruskal Wallis tests were then used to test whether there was a significant difference in the 
distribution of each continuous and ordinal semen analysis parameter in the three BMI 
categories. 
 
Table 7 (page 32) summarises the descriptive statistics of the continuous semen 
parameters (volume, pH, motility, and concentration) as well as the many-category ordinal 
variable morphology, classified by BMI. The SFP data is rather described as a comparative 
bar chart (Figures 5, page 33). 
 
The parameters that appear to have the greatest differences between the subpopulations 
are motility and volume. Box plots of these two sets of subpopulations are displayed in 
Figure 6 (page 34). Neither these differences nor the differences in any other parameter 
across the subpopulations were significantly different, as measured by the Kruskal Wallis 
tests (shown in Table 8, page 35). 
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Table 7 – Descriptive statistics of the semen analysis parameters of each group of 
normal/overweight/obese patients, as classified by BMI. 
    N Mean Median Std. Dev Min Max Percentile  
25 
Percentile  
75                 
Volume 
Normal 31 2.523 2.5 0.9517 1 5 2 3 
Overweight 34 3.603 3.25 1.9839 1 9 2 4.5 
Obese 26 2.962 2.5 1.612 1 7 1.5 4 
pH 
Normal 31 7.497 7.5 0.2927 7 8 7.5 7.5 
Overweight 34 7.456 7.5 0.2389 6.7 8 7.5 7.5 
Obese 26 7.469 7.5 0.3296 6.7 8 7.2 7.7 
Motility 
Normal 31 43.39 45 12.74 20 65 35 55 
Overweight 34 47.5 50 14.681 0 80 40 55 
Obese 26 50.38 55 15.616 0 70 40 60 
Concentration 
Normal 31 53.203 40 39.897 12 140 25 80 
Overweight 34 56.506 39.1 34.8206 15 130 30 80 
Obese 26 65.154 45 39.5097 17 130 30 92 
Morphology 
Normal 31 5.03 4 3.104 1 16 3 7 
Overweight 34 5.47 5 2.377 2 11 3 7 
Obese 26 5.35 5 2.244 1 9 4 7 
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Figure 5 – Frequency of the SFP categories recorded in the three BMI categories. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 34 
 
Figure 6 – The distribution of volume and motility measurements in the three BMI 
categories. 
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Table 8 – Test statistics indicating the probability of homogeneity in each semen analysis 
parameter between individuals with normal, overweight and obese BMI values, tested 
using Kruskal-Wallis H test. 
 
Dependent variable Test 
statistic 
p-value 
Viscosity 1.355 0.508 
SFP 1.710 0.425 
pH 0.243 0.886 
Volume 4.964 0.084 
Motility 5.489 0.064 
Concentration 4.063 0.131 
Morphology 1.531 0.465 
a:Significance at p < 0.05 
b: All categorised by BMI 
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5.3.4 CLASSIFIED BMI VALUES VERSUS CLASSIFIED FERTILITY MEASURES  
In the final step of the analysis, individuals were classified by both their BMI (giving three 
categories) and by each semen analysis parameter.  
 
Using three categories for BMI and two categories for each measurement of semen analysis 
(normal or abnormal) resulted in a series of 3x2 frequency tables. Once again, both 
categorised and uncategorised SFP were checked. Unclassified SFP resulted in a 3x5 
frequency table. Only the frequency tables for BMI, motility, and morphology are shown 
(Table 9, page 36). 
 
Table 9 – Frequency table for motility (normal and abnormal) and BMI (normal, 
overweight and obese); Frequency table for morphology (normal and abnormal) and BMI 
(normal, overweight and obese). 
 Motility Total 
<40 >=40 
BMI <25 17 21 38 
25-30 11 28 39 
>30 7 22 29 
Total 35 71 106 
 
Each of the frequency tables was then analysed using Pearson’s chi-square test and Fisher’s 
exact test. If at least one cell in a frequency tables has a value of less than five, the Fisher 
exact test is more appropriate than the Pearson’s chi-square test.  
 
The results of the categorical tests are shown in Table 10 (page 37). No association between 
BMI categories and normal/ abnormal semen parameters were found. 
 
As a final test, the combined effect of all of the parameters was tested. If an individual had 
at least one semen analysis parameter with an abnormal value, then that individual was 
 Morphology Total 
<4  >=4 
BMI <25 12 19 31 
25-30 9 25 34 
>30 5 21 26 
Total 26 65 91 
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classified as abnormal. According to this final analysis, BMI values did not differ when 
comparing participants who had only normal semen parameters with those who had one or 
more abnormal parameters (Table 10, below). 
 
Table 10 - Results of categorical tests for the BMI and semen analysis variables.  
 
Variable Test Test Statistic d.f. p-value 
SFP* Pearson Chi-Square 4.667
a
 8 .792 
Fisher's Exact Test 4.907   .806 
pH Pearson Chi-Square .174
a
 2 .917 
Fisher's Exact Test .270   .940 
Volume Pearson Chi-Square .831
a
 2 .660 
Fisher's Exact Test .794   .732 
Motility Pearson Chi-Square 3.802
a
 2 .149 
Fisher's Exact Test 3.646   .158 
Concentration Pearson Chi-Square 2.861
a
 2 .239 
Fisher's Exact Test 2.831   .246 
SFP (Re-categorised) Pearson Chi-Square 1.325
a
 2 .515 
Fisher's Exact Test 1.379   .588 
Morphology Pearson Chi-Square 1.761
a
 2 .415 
 Fisher's Exact Test 1.787   .412 
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6.  DISCUSSION 
6.1  QUANTITATIVE AND QUALITATIVE BMI FINDINGS 
The results of this study provide local demographic data not previously described. Our 
recruit BMIs were well distributed across the three categories of normal, overweight, and 
obese. The mean BMI of men presenting to the unit as part of an infertility investigation 
was 27.1kg/m2. These findings are similar to those published by Eskandar et al. (2011). The 
distribution of men across the weight categories was more proportional than that 
measured by Leisegang et al., (2014). In comparison to the findings of Ng et al. (2014), this 
sample had a similar proportion of overweight men (38% vs 37%), but a higher proportion 
of obese men (14% vs 25%). These values are also higher than the previously quoted figures 
from both the 1998 South African Demographic Health Survey and the Case et al., 
Khayelitsha House Survey (2004). Although the current findings were based on a small, 
urban sample population, they suggest that the prevalence of overweight and obesity are 
increasing.  
 
As documented in the preceding literature review, very little is known about South African 
men’s perception and beliefs about body image. When asked to assess their general 
weight, almost 60% of the men underestimated their true weight. Twenty-eight percent of 
these men were incorrect in their self-assessment by two BMI categories. The 2% of men 
who felt they were obese were not.  These findings mirror those reported by Case et al. 
(2009), who demonstrated a general underestimation of body weight. This finding becomes 
significant when considering literature that was based on self-reported BMI.  
 
Less than half of the men felt that there was a relationship between increased body habitus 
and fertility difficulties. One-third of the men responded that they were not sure. This 
perception would need to be addressed should this relationship ever be proven. It may also 
reflect a societal disregard about the risks of being overweight and associated health 
implications in general. 
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An overwhelming 87% of the participants said that they would partake in a weight loss plan 
if one was prescribed as part of the fertility treatment. Of the eight men who admitted that 
they would not, five did not need to lose weight as their BMI fell within a healthy range – a 
fair reply. Whether this reflects the men’s desire to conceive or an actual wish to achieve a 
healthier lifestyle is unclear. This finding is encouraging and suggests clinicians should 
address issues of lifestyle and weight loss in all clinical encounters. The effects of obesity 
reach further than fertility, and this finding has important applications in general practice. 
Pathways to facilitate lifestyle advice and assistance should be clearly defined and offered 
to all patients. 
 
6.2  SEMEN ANALYSIS FINDINGS 
6.2.1  IMPORTANCE OF CATEGORISING SEMEN ANALYSIS VALUES 
Most research has focused on an association between BMI and semen analysis parameters 
as a continuous variable regardless of whether the change represents a clinically significant 
finding.  Jensen et al. (2004) found a significant difference between the median total sperm 
count of men with a BMI greater than 25 kg/m2 (138 million per ejaculate) and obese men 
(116 million per ejaculate). The median BMI value for the obese men was lower but it did 
not represent a clinically abnormal value. Aggerholm et al. (2008) demonstrated a decrease 
in sperm concentration and total count in overweight men only. These results were not 
statistically significant, and the mean values for this group were still well above normal 
ranges. More recently, Belloc et al. (2014) found that increasing BMI was associated with a 
decrease in all semen analysis parameters, except for morphology. The lower means were 
again not below clinically relevant thresholds. The current study focussed on findings of 
clinical relevance, not decreasing trends.  
 
6.2.2 PREVALENCE OF SEMEN ANALYSIS ABNORMALITIES 
Many sources quote a figure of between 35 and 50% of male factor involvement in 
infertility. Our study found that only 29% of men had a completely normal semen analysis 
by published 2010 WHO standards. A single abnormal parameter can however not 
necessarily be extrapolated to infertility rates. 
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6.2.3 SEMEN VOLUME 
Eighty-three percent of the participants had a normal semen volume. Causes of an 
abnormal volume may include non-abstinence, obstructive pathology, or seminal vesicle 
pathology. All of the men had to confirm three days of abstinence, but we did not screen 
for anatomical pathology in our sample. Of the 17% of men with an abnormal semen 
volume, five had a sperm concentration of 0 or too low to allow morphology to be tested. 
 
There was no correlation between the collected values for volume and BMI. There was no 
difference between the BMIs of men classified with normal or abnormal semen volume, nor 
a significant difference between the volumes measured in men categorised as normal, 
overweight, or obese. A categorical analysis showed no correlation between volume and 
BMI. This negative result is in line with the only other South African data published by 
Leisegang et al. (2014), as well as Relwani et al., (2011), and Eskandar et al., (2011). Volume 
findings are not commonly included in studies assessing BMI and infertility relationships, 
but Shayeb et al. (2011) found a correlation between decreasing volume and increasing 
BMI. The author’s volume lower reference limit was 2.0 ml. This is in keeping with former 
WHO guidelines. Chavarro et al. (2010) also found a decrease in semen volume in obese 
men, but again the reference limit was cited as 2.0 ml. This may account for the differences 
observed. 
 
6.2.4  SEMEN PH 
The mean pH of our cohort was 7.5, with 86% of men having a pH that fell within the 
normal range. There was no correlation between semen pH and BMI in this sample, either 
in comparing the two sets of measured data, or comparing BMI (pH) distributions across 
subpopulations divided by their pH (BMI). There is little existing comparison between 
abnormal seminal pH and BMI in published literature.  
 
6.2.5 MOTILITY 
Motility revealed some of the more interesting results. The mean motility was 41.8%. Only 
62.8% of the men had a normal motility. Not surprisingly, a significant, strong, positive 
correlation was found between motility and SFP of 0.693 (p <0.001) when comparing them 
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as continuous variables. Motility and SFP do not have a perfect correlation, yet both are 
measures of how well sperm move. Motility and sperm concentration were also strongly 
correlated (0.676, p<0.01) as continuous variables, suggesting a higher concentration 
results in higher numbers of normal motile sperm. 
 
BMI (as a continuous variable) and motility were weakly correlated (0.263) at the 1% level. 
When motility was categorised into normal and abnormal subgroups, the median BMI in 
the less motile group (24.98 kg/m2) was found to be significantly lower than in the normal 
motility group (27.55 kg/m2). This correlation disappeared when BMI was categorised into 
WHO groups and compared with either the raw motility data or the categorised motility 
scores. This result suggests that the weak correlation found does not have any clinical 
impact. The motility results changed with variations in BMI, but there was no clear 
difference between the findings in the men with a healthy BMI versus those who were 
overweight or obese. We therefore conclude there is no clinically important relationship 
between BMI and motility. 
 
Jensen et al. (2004), Shayeb et al. (2011), and Relwani et al. (2011) found no correlation 
between motility and BMI.  These studies included large sample sizes. Jensen et al. (2004) 
used Danish military recruits, thus avoiding an already known infertility investigation 
cohort. Shayeb et al. (2011) performed a retrospective study but had an obesity incidence 
similar to their study population’s national data. Relwani et al. (2011) used self-reported 
BMI. Two large meta-analyses also showed no relationship between BMI and motility 
(MacDonald et al., 2010; Sermondade et al., 2012).  
 
These findings are in contrast to Fejes et al. (2005), and Hammoud et al. (2008) who both 
demonstrated a relationship between motility and BMI, or other measure of obesity. Fejes 
et al. (2005) used normal motile sperm cells (NMS) as their measure of motility, which 
involved multiplication of volume, motility, morphology and total count. They did not 
stipulate a normal NMS value. The clinical significance of these results is therefore unclear. 
The correlation was with weight alone, not BMI. Their findings cannot be directly compared 
to studies assessing pure motility.  
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Hammoud et al. (2008) had a very high proportion of overweight and obese males, which 
was not representative of a normal population. Their data was represented in terms of 
odds ratios and prevalence percentages, and was based on older, now outdated, reference 
values. They used progressively motile sperm (10 x 106 motile sperm per ejaculate) as their 
motility measure. As they did not publish mean data, the clinical significance of their 
findings cannot be commented on. Again, these results cannot be directly compared. 
 
6.2.6 SPERM FORWARD PROGRESSION 
Sperm forward progression (SFP) refers to a grading of how many motile sperm are moving 
in a forward direction. It was graded by the analysis laboratory from 0 to 4 where a value of 
2 was normal. Eighty-four percent of men had a normal SFP.  
 
The strong correlation between the collected scores for motility and SFP has been discussed 
above. SFP was also moderately correlated with sperm concentration (0.586, p<0.01), 
suggesting that a higher concentration of sperm results in more forwardly progressive 
motile sperm.  
 
There was no correlation between the collected values for SFP and BMI. There was also no 
significant difference between the BMIs of men classified with normal or abnormal SFP, nor 
a significant difference between the SFP measured in men categorised as normal, 
overweight, or obese. A categorical analysis showed no correlation between volume and 
SFP. This is not a parameter often commented on in the literature. We conclude there is no 
clinically significant relationship between BMI and SFP.  
 
6.2.7 SPERM CONCENTRATION 
The mean sperm concentration was found to be 47.3 x 106/ml. Oligozoospermia (defined as 
< 15 x 106 per ml) was present in 20.35% of men, including seven with azoospermia.  
 
As discussed above, sperm concentration was correlated moderately with SFP and strongly 
to motility (0.586 and 0.676 respectively, p<0.01). Concentration was weakly correlated 
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with morphology (0.325, p<0.01), again illustrating that an increased concentration results 
in a higher chance of morphologically normal sperm.  
 
There was a very weak correlation between the collected BMI and concentration scores 
(0.186, p < 0.05). The mean BMI of men in both the normozoospermic and oligozoospermic 
groups were similar, at 26.6 kg/m2 and 27.7 kg/m2 respectively. This correlation 
disappeared when concentration was categorised as normal or abnormal, or when BMI was 
categorised as normal, overweight, or obese. We conclude there is no clinically significant 
relationship between BMI and sperm concentration according to our results. 
 
This result is again in keeping with the only available South African data by Leisegang et al. 
(2014). Relwani et al. (2011) also found no relationship between concentration and BMI. 
Chavarro et al. (2010) found only an insignificant, weak correlation after dichotomised 
statistical analysis.  
 
In contrast, Jensen et al. (2004) showed a decrease in sperm concentration of 21.6%, using 
now outdated reference values. The mean sperm concentration remained at 39 x 106/ml, 
which falls into the current WHO guideline’s normal range. The clinical significance of this is 
questionable. Fejes et al. (2005) only found a correlation between sperm concentration and 
hip circumference, which is not an accepted measurement of obesity. They found no 
anthropometric differences between the oligozoospermic and normozoospermic groups. 
 
Hammoud et al. (2008) found a definite increase in the incidence of oligozoospermia as BMI 
increased. They used 20 x 106/ml as their cut off, a higher value than is currently accepted. 
The BMI in this study was self-reported. The results collected here showed that men tend 
to incorrectly estimate their weight, making self-reporting a very inaccurate tool and any 
results based on this equally inaccurate. There was also a very high incidence of overweight 
and obese recruits in the Hammoud et al. (2008) study, which may have skewed the results.  
 
Sermondade et al. (2012) conducted a meta-analysis that showed a J-shaped curve 
between BMI and sperm concentration. The odds ratio of a sperm concentration of < 15 x 
106/ml was 1.06 and 1.31 in BMI values over 25 and 30 kg/m2 respectively. The largest 
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increase was found in men with a BMI > 35 kg/m2, showing an odds ratio of 1.97. These 
results were not seen until the data was dichotomised for analysis. Our sample only 
included six men with a BMI of over 35 kg/m2, so this analysis was not done.  
 
6.2.8  MORPHOLOGY 
Morphology was analysed in 91 of our recruited men. The mean morphology was 5%, with 
57.52% of samples analysed having a morphology result within the normal range.  
 
The collected morphology results were moderately correlated with concentration (0.325, p 
< 0.01). These results have already been discussed in the above text.  
 
No correlation between BMI and morphology was found by comparing collected values, 
categorising BMI or morphology values, or by categorising both variables and comparing 
the frequencies. This is in keeping with the findings of three studies (Jensen et al., 2004; 
Relwani et al., 2011; Belloc et al., 2014).  
 
Shayeb et al. (2011) found a decreasing percentage of normal morphologies as the BMI 
category increased. The lowest of these values was 6%, which is still above the WHO lower 
limit reference ranges used today and is thus clinically insignificant. Chavarro et al. (2010) 
found only an insignificant, weak correlation after dichotomised statistical analysis. 
 
Two meta-analyses (Macdonald et al., 2010; Sermondade et al., 2012) also found no 
correlation between morphology and BMI. 
 
 
 
 
 
6.2.9 COMPARISON OF FINAL RESULTS WITH PUBLISHED DATA 
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Al-Ali et al. (2014) conducted a 16-year retrospective analysis of men presenting to an 
infertility clinic. Their findings support those of the current study in concluding that BMI has 
no effect on semen analysis parameters. They applied two sets of WHO semen analysis 
guidelines (1992 and 1999) to their data. Both guidelines are currently outdated, and the 
use of two measures of normal is questionable. 
 
Our findings are in keeping with the Macdonald et al. (2010) meta-analysis, which found no 
relationship between BMI and any of the semen analysis parameters. They included 13 
studies of 6 793 men in total. None of the studies had less than 100 participants. In 
contrast, Sermondade et al. (2012) conducted a later meta-analysis of 13 studies (13 077 
men) and found a significant relationship between total count (not analysed in our study) 
and sperm concentration. This analysis was conducted using currently accepted WHO 
semen analysis guidelines. They did not find a relationship when comparing 
normozoospermia and oligozoospermia. However, a difference was found when the 
oligozoospermia group was divided into azoospermia and oligozoospermia.  
 
The only local data to the author’s knowledge is that of Leisegang et al. (2014). They found 
a decrease in sperm concentration with increasing BMI, but this was not of clinical 
significance with a mean value of 23.7 x 106/ml. As the current study was concerned with 
findings of clinical relevance, these results are not necessarily contradictory. We did not 
measure vitality and therefore cannot comment on this finding.  
 
6.3  STUDY STRENGTHS AND WEAKNESSES 
The sample size of 113 men may be viewed as a study limitation. However, our sample size 
is almost three times larger than that of the only other South African data available (40 
men) and significantly larger than the sample size used by Fejes et al. (2005).  
 
 
There was a good distribution of overweight and normal-weighted men across the three 
BMI categories, allowing each category to be analysed separately. This is in contrast to 
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Leisegang et al. (2014), who grouped overweight and normal-weighted men together. BMI 
was also measured directly, making this study’s BMI results more accurate than many 
international studies that cite self-reported or partner-reported weight and height. 
 
This study assessed men’s perceptions of their body image and the impact of weight on 
fertility, as well as their said acceptance of weight loss measures if implemented in fertility 
management. This provides new information on the local population.  
 
7.  CONCLUSIONS AND RECOMMENDATIONS FOR FURTHER RESEARCH 
This study has demonstrated a larger prevalence of obesity in South African men than has 
previously been documented, as well as the inability of men to accurately self-report where 
they fall on the weight curve in terms of BMI. We also demonstrated a mixed opinion about 
the effects of weight on fertility and that most men were willing to accept advice on weight 
loss. The European Society for Human Reproduction and Embryology task force on ethics 
and law recommend weight loss as part of fertility treatment in women (Dondorp et al., 
2010). The consultation with a couple seeking fertility advice should therefore encourage 
behaviour modification counselling.  
 
We conclude that there is no difference between normal, overweight and obese South 
African men in terms of clinically significant semen analysis markers for infertility in our 
study.  
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8.  APPENDIX A: SUMMARY OF EPIDEMIOLOGICAL STUDIES 
 
 
Study Participants Sample Size Results Notes and Summary of 
Findings 
Sallmén 
et al., 
2006 
Secondary analysis 
of data extracted 
from the 
Agricultural Health 
Study (Pesticide 
applicators and 
spouses). 
 
United States of 
America. 
1 329 couples 
(initial study 
comprised of 
52 395 pesticide 
applicators). 
BMI>30 associated 
with odds ratio 1.12 
(CI 95% 1.01-1.25) 
of infertility. 
 
Dose-response 
relationship 
between increasing 
BMI and infertility. 
Very high baseline infertility 
rate of 28%. 
 
BMI self-reported, not at 
time of reported infertility. 
 
 
Infertility defined as 12 
month period of no 
conception in a 4 year study 
period. 
Ramlau-
Hansen et 
al., 2007 
Extracted data from 
the Danish National 
Birth Cohort. 
 
Denmark. 
47 835 women 
and their male 
partners. 
BMI>25 associated 
with odds ratio of 
1.15 (95% CI 1.09-
1.22) of infertility. 
 
BMI>30 associated 
with odds ratio of 
1.49 (95% CI 1.34-
1.64) of infertility. 
 
Dose-response 
relationship 
demonstrated 
Subfecundity defined as 12 
months to achieve a 
pregnancy resulting in live 
birth - excluded couples who 
ultimately did not conceive, 
or who miscarried (due to 
register only documenting 
live births). 
 
BMI reported 2 years after 
the attempted pregnancy. 
Nguyen 
et al., 
2007 
Secondary analysis 
of a Norwegian 
database (Mother 
and Child Cohort 
Study). 
 
Norway. 
26 303 women 
and their male 
partners. 
BMI >25 associated 
with odds ratio for 
infertility of 1.19 
(95% CI 1.03-1.62). 
 
BMI >30 associated 
with an odds ratio 
of 1.36 (95% CI 
1.12-1.62). 
 
Dose-response 
relationship 
demonstrated. 
Infertility defined as 12 
months to time of 
pregnancy, resulting in live 
birth. 
 
Self-reported BMI at time of 
pregnancy. 
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9.  APPENDIX B: SUMMARY OF INFERTILITY CLINIC STUDIES 
 
 
 
 
 
Study Participants Sample Size Results Notes 
Magnusdottir 
et al.,2005 
Men who had 
previously had 
semen analysis 
done at the 
tertiary 
hospital. 
 
Iceland. 
72 men 
 
25 men male factor subfertility 
(MFS) 
 
20 men idiopathic subfertility 
(IS) 
 
27 men female factor 
subfertility (FFS) 
 
MFS: 
prevalence 
of obesity: 
40% 
 
IS: 
prevalence 
of 
obesity:5% 
 
FFS: 
prevalence 
of obesity: 
10% 
Primary objective 
comparing levels 
polychlorinated biphenyls 
and organochlorine 
pesticides in plasma and 
semen to assess 
environmental impact on 
fertility. 
 
BMI measures as a 
secondary outcome. 
Zorn et al., 
2006 
Male partners 
of infertile 
couples. 
 
Slovenia. 
210 men 
 
Non-obstructive azoospermia 
n=42 
Obstructive azoospermia 
n=15 
Oligoasthenoteratozoospermia 
n=86 
Normozoospermia  
n=85 
 
 
 
BMI 27.15 
 
BMI 26.75 
 
BMI 26.22 
 
BMI 25.52 
Small increase in BMI 
among males with non-
obstructive azoospermia 
relative to 
normozoospermic men. 
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10. APPENDIX C: WHO SEMEN ANALYSIS REFERENCE RANGES (Menkveld., 2010) 
Parameter 1992 
Lower Reference 
Limit 
1999  
Lower Reference 
Limit 
2010 
Lower Reference 
Limit 
Volume (ml) 2.0 2.0 1.5 
pH Not specified Not specified >7.2 
Motility (%) 50 50 40 
Sperm 
concentration  
(106 per ml) 
20 20 15 
Morphology  
(normal forms, %) 
30  
(arbitrary value) 
14 4 
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11.  APPENDIX D: SUMMARY OF STUDYS COMPARING BMI WITH SEMEN ANALYSIS 
RESULTS 
Study Participants Sample Size Results Notes and Summary of 
Findings 
Jensen et 
al., 2004 
Danish military 
recruits. 
 
Denmark. 
1 558 men 
 
BMI < 20  
n = 217 
BMI 20-25  
n = 1042 
BMI > 25 
 n = 299 
Volume (ml) 
BMI < 20 = 3.0 
BMI  20-25  = 3.2 
BMI > 25 = 3.2 
 
Concentration (10
6
/ml) 
BMI < 20 = 40 
BMI  20-25  = 46 
BMI > 25 = 39 
 
Total sperm count 
BMI < 20 = 105 
BMI  20-25  = 138 
BMI >25 = 116 
 
Motility (%) 
BMI < 20 = 63.7 
BMI  20-25  = 65.4 
BMI > 25 = 65.5 
 
 
 
Morphology (%) 
BMI < 20 = 6.8 
BMI  20-25  = 7.4 
BMI > 25 = 7.1 
 
Subjects underwent 
questionnaire, physical 
examination, endocrine 
testing. 
 
Statistical correction for 
diseases of the reproductive 
organs. 
 
WHO 1992 semen analysis 
parameter lower reference 
ranges used. 
 
BMI >25 kg/m
2
 had a 21.6% 
decrease in their sperm 
concentration vs <25 kg/m
2
 
counterparts. 
 
Total sperm count was also 
reduced by 23.9%. 
  
No link between BMI and 
sperm motility, volume, or 
morphology was found. 
Fejes et al., 
2005 
Couples presenting 
to infertility clinic. 
 
Hungary. 
81 couples. Concentration (10
6
/ml) 
Sperm concentration 
negatively correlated 
with increasing hip 
circumference (r=-0.24; 
p=0.033).  
 
 
 
Questionnaire, medical, 
endocrine testing. 
 
Waist-hip ratio calculated. 
 
Men with secondary 
infertility excluded. 
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Total sperm count 
(millions) 
Total sperm count 
negatively correlated to 
increasing hip 
circumference (r=-0.22, 
p=0.009), 
Weight (r=-0.024, 
p=0.031),  
Waist circumference (r=-
0.26, p=0.007). 
 
Motility 
Correlation between 
body weight and total 
motile sperm count (r=-
0.22, p=0.048) 
 
Morphology 
No anthropometric 
differences between 
groups with normal and 
abnormal motility. 
 
No mean values 
provided. 
Two semen samples taken -
best result used. 
 
WHO 1999 semen analysis 
parameter lower reference 
ranges used. 
Kort et al., 
2006 
Men presenting to 
infertility clinic. 
 
United States of 
America. 
520 men. Significant negative 
relationship between 
raised BMI and normal-
motile sperm cells 
(NMS). 
 
BMI <25 NMS =18.6 
BMI>25 NMS = 3.6 
BMI>30 NMS = 0.7 
 
NMS = volume × 
concentration × 
%motility × 
%morphology. 
Numbers of men in each 
weight category not stated. 
 
Limited outcome data. 
 
 
WHO 1999 semen analysis 
parameter lower reference 
ranges used. 
No definition of normal 
values for NMS. 
Aggerholm 
et al., 2008 
Data from five 
previous 
population-based 
environmental 
1 989 men. 
 
BMI < 20 
n = 67 
Concentration 
BMI < 20 = 82 
BMI <25 = 74 
BMI >25 = 70 
Results re-classified with 
WHO BMI categories – no 
difference found. 
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studies of semen 
quality were 
combined into one 
Database.  
 
Denmark. 
BMI <25 
n = 986 
BMI >25 
n = 773 
BMI> 30  
n = 163 
BMI> 30 = 80 
 
Total sperm count 
(millions) 
BMI < 20 = 256 
BMI <25 = 231 
BMI >25 = 216 
BMI> 30 = 265 
 
Motility (%) 
BMI < 20 = 42 
BMI <25 = 41 
BMI >25 = 48 
BMI> 30 = 54 
Self-reported height and 
weight. 
 
Analysed for cofounders. 
 
WHO reference ranges not 
specified. 
 
Normal weighted men had a 
higher sperm concentration 
and total sperm count than 
overweight men. 
 
Normal weighted men had a 
lower sperm concentration 
and total sperm count than 
obese men. 
 
None of results statistically 
significant. 
Hammoud 
et al., 2008 
Male partners of 
couples presenting 
to infertility clinic. 
 
United States of 
America. 
390 men. 
 
BMI < 25  
n = 94 
BMI > 25 
 n = 168 
BMI > 30  
n = 128 
 
Total sperm count – in 
terms of incidence of 
oligozoospermia(%) 
BMI < 25 = 5.32 
BMI >25 = 9.52 
BMI>30 = 15.62 
 
Motility in terms of 
incidence of low 
progressively motile 
sperm count (%) 
BMI < 25 = 4.25 
BMI >25 = 8.93 
BMI>30 = 13.28 
Morphology 
OR of abnormal 
morphology in obese 
group 1.6 (95% CI 1.05 – 
2.59) 
 
No mean values 
provided. 
Secondary causes of 
infertility excluded. 
 
High proportion of 
overweight and obese 
participants. 
 
 
Weight and height self-
reported. 
 
WHO 1999 semen analysis 
parameter lower reference 
ranges used. 
 
Obesity was associated with 
increased odds ratio for 
oligozoospermia. 
 
Obese men had higher 
abnormal morphology 
incidence. 
 
Obese men had lower 
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progressively motile sperm 
count incidence. 
Chavarro et 
al., 2010 
Men presenting to 
an infertility clinic. 
United States of 
America 
384 men. 
 
BMI < 25  
n = 123 
BMI > 25  
n = 233 
BMI > 30 
n = 87 
BMI > 35  
n = 40 
Concentration (10
6
/ml) 
BMI < 25 = 76 
BMI > 25 = 81 
BMI > 30 = 87 
BMI > 35 = 77 
 
Sperm motility (%) 
BMI < 25 = 49 
BMI > 25 = 55 
BMI > 30 = 54 
BMI > 35 = 55 
 
Morphology (%) 
BMI < 25 = 7 
BMI > 25 = 7 
BMI > 30 = 7 
BMI > 35 = 6 
 
Volume (ml) 
BMI < 25 = 3.2 
BMI > 25 = 2.9 
BMI > 30 = 3.0 
BMI > 35 = 2.6 
 
Total progressive sperm 
count (millions) 
BMI < 25 = 63 
BMI > 25 = 71 
BMI > 30 = 71 
BMI > 35 = 55 
 
Directly measured BMI. 
 
Underweight and 
azoospermic men excluded 
from analysis. 
 
WHO 1999 semen analysis 
parameter lower reference 
ranges used. 
 
Increasing BMI associated 
with a decreasing semen 
volume. 
 
Overweight men have a 
higher total progressive 
sperm count than their 
normal-weighted 
counterparts – unexplained. 
Eskandar et 
al., 2011 
Men presenting to 
infertility centre. 
 
Saudi Arabia. 
500 men. 
 
BMI < 30  
n = 322 
BMI > 30 
n = 178 
Volume (ml) 
BMI < 30 n = 2.5 
BMI > 30 n = 2.5 
 
Concentration (10
6
/ml) 
BMI < 30 n = 40 
BMI > 30 n = 40 
 
 
Retrospective study 
 
Direct measurement BMI. 
 
Results all p > 0.05. 
 
WHO 1999 semen analysis 
parameter lower reference 
ranges used. 
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Total count (millions) 
BMI < 30 n = 81.5 
BMI > 30 n = 93 
Motility (%) 
BMI < 30 n = 49 
BMI > 30 n = 50 
 
Morphology (%) 
BMI < 30 n = 17 
BMI > 30 n = 17 
 
No relationship between 
BMI and semen analysis 
parameters. 
Relwani et 
al., 2011 
Men who had a 
semen 
analysis at 
Montefiore Institute 
for Reproductive 
Medicine and 
Health or at MAZE 
Andrology 
Laboratory. 
 
United States of 
America. 
530 men. 
 
No 
breakdown 
of men per 
BMI category 
provided 
Volume (ml) 
BMI 15.15 - 25.8 = 2.93 
BMI 25.82 - 29.68 = 2.73  
BMI 29.7 - 60.69 = 3.01 
 
Concentration (10
6
/ml) 
BMI 15.15 - 25.8 = 57.95 
BMI 25.82 - 29.68 =  
56.94 
BMI 29.7 - 60.69 =  51.28 
 
Motility (%) 
BMI 15.15 - 25.8 = 53.71 
BMI 25.82 - 29.68 = 
54.84 
BMI 29.7 - 60.69 =  53.06 
 
Morphology (%) 
BMI 15.15 - 25.8 = 10.79 
BMI 25.82 - 29.68 = 
10.28 
BMI 29.7 - 60.69 = 10.53 
Secondary causes of 
infertility excluded. 
 
Weight and height self-
reported. 
 
2010 WHO criteria used. 
 
No consistent relationship 
between sperm 
concentration, motility, or 
morphology and increasing 
BMI. 
Shayeb et 
al., 2011 
Male partners of 
couples undergoing 
fertility 
investigations. 
 
Scotland. 
2 035 men. 
 
BMI < 18.5 
 n = 18 
BMI <25  
n = 839 
BMI >25  
n = 909 
BMI >30 
n = 269 
Volume (ml) 
BMI < 18.5 = 3.2 
BMI < 25 = 3.5 
BMI > 25 = 3.5 
BMI > 30 =3.2 
 
Concentration (10
6
/ml) 
BMI < 18.5 = 45.9 
BMI < 25 = 47.9 
BMI > 25 = 47.0 
Proportion of overweight to 
normal weighted men 
representative of 
population. 
 
Retrospective analysis of 
data from 1990 – 2007. 
 
WHO 1999 semen analysis 
parameter lower reference 
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BMI > 30 = 50.8 
 
 
Total Sperm Count 
(millions) 
BMI < 18.5 = 147.2 
BMI < 25 = 144.0 
BMI > 25 = 153.0 
BMI > 30 =162.7 
 
Motility (%) 
BMI < 18.5 = 40.8 
BMI < 25 = 45.0 
BMI > 25 = 45.4 
BMI > 30 =47 
 
Morphology (%) 
BMI < 18.5 = 11.0 
BMI < 25 = 9.0 
BMI > 25 = 8.0 
BMI > 30 =6.0 
ranges used. 
 
 
No association between BMI 
and sperm concentration, 
total sperm count, 
progressive motility, semen 
volume, or the total number 
of morphologically normal 
and progressively motile 
spermatozoa per ejaculate. 
 
Sperm with normal 
morphology more prevalent 
in the normal and 
underweight men than in the 
overweight and obese men. 
Al-Ali et al., 
2014 
16 year 
retrospective study 
of men presenting 
to infertility clinics 
in Austria and 
Germany. 
2110 men. 
 
BMI < 18.5  
n = 16 
BMI < 25  
n = 1082 
BMI > 25 
n = 821 
BMI > 30  
n = 191 
Mean pathological 
sperm morphology (%) 
BMI < 25 = 63 
BMI > 25 = 62 
BMI > 30 = 63 
BMI > 35 = 63 
 
Mean sperm 
concentration (%) 
BMI < 25 = 30.7 
BMI > 25 = 63.09 
BMI > 30 = 66.39 
BMI > 35 = 62.06 
 
Mean sperm motility 
(%) 
BMI < 25 = 20.94 
BMI > 25 = 24.59 
BMI > 30 = 24.76 
BMI > 35 = 24.53 
 
Direct measurement of BMI. 
 
Use of two different WHO 
criteria 5 years into study 
(1992; 1999). 
 
No impact of BMI on semen 
analysis parameters. 
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Belloc et 
al., 2014 
Men presenting to 
an infertility clinic. 
 
France. 
10 665 men. 
 
BMI < 18.5 
n = 27 
BMI < 25  
n = 5799 
BMI > 25  
n = 3607 
BMI > 30  
n = 634 
BMI > 35  
n = 97 
BMI > 40 
n = 33 
Volume (ml) 
BMI < 18.5 n = 3.0 
BMI < 25 n = 3.9 
BMI > 25 n = 3.8 
BMI > 30 n = 3.8 
BMI > 35 n = 4.0 
BMI > 40 n = 3.7 
 
Concentration (10
6
/ml) 
BMI < 18.5 n = 49.5 
BMI < 25 n = 56.4 
BMI > 25 n = 55.1 
BMI > 30 n = 50.7 
BMI > 35 n = 49.7 
BMI > 40 n = 39.4 
 
Total sperm count 
(millions) 
BMI < 18.5 n = 133 
BMI < 25 n = 171 
BMI > 25 n = 163 
BMI > 30 n = 141 
BMI > 35 n = 136 
BMI > 40 n = 92 
 
Motility (%) 
BMI < 18.5 n = 38.3 
BMI < 25 n = 39.7 
BMI > 25 n = 39.4 
BMI > 30 n = 37.5 
BMI > 35 n = 38.5 
BMI > 40 n =38.0 
 
Morphology (%) 
BMI < 18.5 n = 10.7 
BMI < 25 n = 12.1 
BMI > 25 n = 11.9 
BMI > 30 n = 11.5 
BMI > 35 n = 12.0 
BMI > 40 n =12.5 
Self-assessed BMI recorded. 
 
Second largest study to date. 
 
WHO 2010 semen analysis 
parameter lower reference 
ranges used. 
 
BMI affected all semen 
analysis parameters except 
morphology. 
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12. APPENDIX E: SUMMARY OF RESULTS LEISEGANG ET AL. (2014) 
 
 Non-Obese n=19 Obese n=23 
 Mean (range) Mean (range) P value 
Semen volume (ml) 2.7 (1.2-5.5) 2.5 (0.4-7.0) 0.6217 
Sperm concentration 
(10
6
/ml) 
35.3 (8.8-72.4) 23.7 (7.5-49.5) 0.0145 
Total sperm count (x 10
6
) 96.5 (13.2 – 243.7) 64.4 (3.7-247.5) 0.0863  
Progressive motility (%) 33.8 (0-59.5) 24.5 (0-70.1) 0.0986 
Total motility (%) 52.2 (18.5-78.6) 41.4 (1.1-74.9) 0.1066 
Vitality (%) 62.6 (29-92) 45.0 (6-88) 0.0172 
Normal morphology (%) 2.57 (1-7) 1.95 (0-5) 0.2371 
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13. APPENDIX F: INFORMED CONSENT 
 
IMPACT OF MALE BODY WEIGHT ON SEMEN ANALYSIS PARAMETERS 
(HREC/REF: 171/2014) 
UNIVERSITY OF CAPE TOWN 2014 
 
This study is conducted by Dr. L.J. Oosthuizen, a registrar in the Department of Obstetrics 
and Gynaecology at the University of Cape Town. All men presenting to the Reproductive 
Medicine Unit at the University of Cape Town are invited to enrol in this study. 
 
The aim of this research is to document the body mass index (weight/height2) of men 
presenting to the unit and compare it to the results of their sperm sample analysis. 
 
If you are willing to participate in this study, we will ask you to please fill in a questionnaire, 
and allow us to measure your weight and height. We will ask your permission to use your 
sperm analysis results. Our copy of the results will contain only a participant number, not 
your name. All of the details recorded will be kept anonymous.  
 
There is no monetary incentive to participate in this study. You are allowed to decline 
participation and, should you chose to participate, you may withdraw from the study at any 
point. Your decision to participate will not influence the clinical care that you receive. You 
may ask any questions you feel necessary to determine whether you are willing to 
participate in this study.  
 
SIGNED:       DATE: 
 
WITNESS: 
 
 
STUDY NUMBER: 
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14. APPENDIX G: QUESTIONNAIRE  
QUESTIONNAIRE (HREC/REF: 171/2014) 
 
DATE: 
STUDY NUMBER: 
 
Please read the question and tick the answer you feel is most correct for you: 
 
1. How would you describe your weight? 
 
 
Underweight 
 
 
Normal 
 
Slightly Overweight 
 
Very Overweight 
 
 
2. Do you think being overweight or obese can affect your fertility as a man? 
 
 
Yes 
 
No 
 
I don’t know 
 
 
 
3. If you felt you were overweight, would you follow a weight loss programme if one 
was offered to you as part of your fertility treatment? 
 
 
Yes 
 
 
No 
 
I don’t know 
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